FDA Investigator Barbara Jwilimczyk Macri

Barbara Jwilimczyk Macri has inspections in 7 countries as of 03 Nov 2023. Barbara Jwilimczyk Macri has collaborated with a combinined 4214 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:

Last Inspection Date:

03 Nov 2023

Investigator Role:

FDA Investigator

Redica ID:

100001851

Country:

United States of America, Ireland, France, Italy, Poland, Switzerland, Croatia

Co-Investigator(s):

Addam S Reynolds, Adetutu M Gidado, Alice S Tsao, Amy L Singer, Amy M Codella, Amy M Cramer, Ankur C Patel, Ann Marie Montemurro, Anna M Brannen, Annemarie B Randow, Annemarie Bodnar, Annet R Rajan, Anthony Abel, Anthony J Donato, Ashar P Parikh, Atul J Agrawal, Barbara J Maulfair, Barbara J Rincon, Barbara J Wilimczyk, Byungja E Marciante, Cary Greene, CDR Ileana Barreto Pettit, Charles J Chacko, Cheryl A Clausen, Chiang Syin, PhD, Christine M Cerenzio, Cory Greene, Craig W Swanson, Daniel J Grabicki, Daniel J Min, Daniel W Cline, David A Oluwo, David H Smith, Dawn L Wydner, Deborah B Nixon, Denise M Visco, Investigator, Dennis Cantellops Paite, Devaughn Edwards, Devon Jenkins, Deyaa Shaheen, Dhaval H Patel, Dorothy J Denes, Douglas A Campbell, Douglas C Kovacs, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Edward Oshaughnessy, Elaine E Gilfillan, Emest F Bizjak, Emmanuel J Ramos, Emmanuel Jramos Maldonado, Eric J Cunningham, Eric Rothschild, Erin D Mccaffery, Ernest F Bizjack, Esteban Beltran, Farhana Khan, Frank J Marciniak, Fred Razzaghi, Frederick Razzaghi, George J Flynn, George Pyramides, Gianine E Tompkins, Gobiga Vanniyasingam, Guerlain Ulysse, Helen B Ricalde, Helen Verdel, Himanshu Gupta, PhD, Jacob G Lutz, James A Liubicich, James C Maclaughlin, James R Birkenstamm, Janet A Rajan, Janet L Bowen, Jean M Kelahan, Jeffrey J Ebersole, Jennifer A Bazergui, Jennifer D Hollstrom, Jennifer Macmillan, Jessica M Monteiro, Joey V Quitania, Jogy George, Jonathan G Matrisciano, Joohi Castelvetere, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose M Cayuela, Joseph F Mcginnis, RPh, Joseph Mcginnis, Joy Rkozlowski Klena, Juanita P Versace, Junho Pak, Justine Tomasso, Karen E D'orazio, Karen F Tomaziefski, Karishma G Gopaul, Keith M Reilly, Kelli F Dobilas, Kelli Regente, Kelly Doremus, Kelly I Anderson, Kenneth V Miller, Kerry A Kurdilla, Kim Lthomas Cruse, Kine Thomas Cruse, King, Kinh Q Mac, Ko U Min, Kristen E Rescigno, Kristina L Conroy, Kristy A Zielny, Krystal O Ogunremi, Krystyna M Kitson, Kyle D Covill, Lata C Mathew, PhD, Laura Fontan, MS, Lauren L Vajo, Lawrence R Johnson, Leanna M Slarsky, Li Li, Liatte Kreuger, PharmD, Lisa M Bellows, Lisa M Feola, Loretta Nemchik, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Marea K Harmon, Margaret M Sands, Maria A Bienkowski, Maria A Reed, Maria Estrella, Maria Estrella Jimenez, Marie Bbuen Bigornia, Marjorie D Schultz, Matthew A Spataro, Matthew B Casale, Melba T Rivera, Melba Trivera Clavell, Melissa B Libby, Melissa T Roy, Meredith L Sheridan, Michael A Charles, Michael Gurbarg, Michael R Klapal, Michael Rosner, Michael Serrano, Michele L Obert, Michele Perry Williams, Mielziner, Miguel A Martinez, Mina D Ahmadi, Mindy M Chou, Monika Borkowska, Mra Greenc, Mra Mcculloughj, Nancy F Scheraga, Nancy L Rolli, Nancy M Espinal, Nancy Sheraga, Natasha Gupta, Nerizza B Guerin, Nicholas A Vicland, Nicholas A Violand, Niketa Patel, Nina Yang, Nyungja E Marciente, Odera I Ekwunife, Parul M Patel, Patrice S Hall, Patricia H Dlugosz, Patrick C Klotzbuecher, Paul L Bellamy, Paul Mouris, Paula J Bretz, Peter R Lenahan, Philip F Istafanos, DMV, MS, Pratibha Bhat, Pushpa S Jayasekara, Raymond L Cheung, Regina T Brown, Richard D Manney, Richard E Needham, Robert D Tollefsen, Robin P Mathew, Rochelle L Cross, Rodrigo Vilchez, Rosario D'costa, Rose Ljean Mary, Rose Xu, Russell J Glapion, Sachinkumar V Patel, Saleem A Akhtar, Sandra A Boyd, Sarah Adella Fave, Sarah Forney, Sayyem H Akbar, Schultz, Sean G Casey, Sean R Marcsisin, Sena G Dissmeyer, Sherri J Liu, Shirley S Wen, Sinai Davis, Srinivas R Chennamaneni, PhD, State Agency, Stelios C Tsinontides, Stephanie Mangigian, MS/OSH, RN, Stephanie T Durso, Stephen J Koniers, Stephen J Mottola, Susan M Halsted, Susant Hadman, Tajah L Blackburn, Tamil Arasu, PhD, Tanya R Syffrard, Tara G Bizjak, Tara R Gooen, Terri L Dodds, Thomas E Friel, Tiffani D Wilson, Tonia F Bernard, Tonya R Johnson, Toyin B Oladimeji, Tressa T Lewis, Unnee Ranjan, Valerie C Reed, Victoria Spivak, Viviana Matta, Wayne J Meyer, William Chang, William R Chang, Xiaohan Cai, PhD, Xiaoping Guan, Ying Zhang, Yuesheng Ye, Yvesna C Blaise, Yvins Dezan, Zachary L Miller, Zakaria I Ganiyu, Zhongren Wu

Barbara Jwilimczyk Macri's Documents

Publish Date	Document Type	Title
February, 2013	FDA 483	Wedgewood Village Pharmacy, LLC - Form 483, 2013-02-11
April, 2016	FDA 483 Response	Akorn Operating Company LLC (dba Akorn) - Form 483R, 2016-04-26
March, 2015	FDA 483 Response	Kobo Products, Inc - Form 483R, 2015-04-03
January, 2012	EIR	Actavis Elizabeth LLC - EIR, 2012-01-13
October, 2013	EIR	Hikma Pharmaceuticals USA Inc. - EIR, 2013-10-22
April, 2010	FDA 483	Vantage Specialty Ingredients, Inc - Form 483, 2010-04-08
October, 2015	FDA 483	Appco Pharma LLC - Form 483, 2015-10-06
October, 2015	FDA 483 Response	ACINO PRODUCTS LIMITED LIABILITY COMPANY - Form 483R, 2015-10-26
October, 2015	FDA 483	ACINO PRODUCTS LIMITED LIABILITY COMPANY - Form 483, 2015-10-26
October, 2015	EIR	Appco Pharma LLC - EIR, 2015-10-06
November, 2011	FDA 483	Medicia Holdings LLC - Form 483, 2011-11-04
May, 2014	FDA 483	Akorn Operating Company LLC (dba Akorn) - Form 483, 2014-05-29
August, 2011	FDA 483	Vitaquest International LLC d/b/a State Nutritionals, Inc. - Form 483, 2011-08-31
July, 2012	FDA 483	Integra LifeSciences Corporation - Form 483, 2012-07-30
October, 2011	FDA 483	Vantage Specialty Ingredients, Inc - Form 483, 2011-10-11
October, 2011	EIR	Vantage Specialty Ingredients, Inc - EIR, 2011-10-11
October, 2016	FDA 483 Response	RARITAN PHARMACEUTICALS INCORPORATED - Form 483R, 2016-11-03
August, 2015	FDA 483	Alcami Corporation - Form 483, 2015-08-26
October, 2013	FDA 483	Hikma Pharmaceuticals USA Inc. - Form 483, 2013-10-22
March, 2015	FDA 483	Kobo Products, Inc - Form 483, 2015-03-13
March, 2014	FDA 483 Response	Sonar Products, Inc. - Form 483R, 2014-04-03
August, 2010	FDA 483	Loricon Testing Service, Inc. - Form 483, 2010-08-12
January, 2014	EIR	Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc. - EIR, 2014-01-08
June, 2013	EIR	Hikma Pharmaceuticals USA Inc. - EIR, 2013-06-14
November, 2010	FDA 483	H & P Industries, Inc. - Form 483, 2010-11-10
April, 2013	FDA 483	Med Prep Consulting, Inc. - Form 483, 2013-04-03
July, 2009	FDA 483	Ingenus Pharmaceuticals NJ, LLC - Form 483, 2009-07-07
March, 2015	EIR	Kobo Products, Inc - EIR, 2015-03-13
April, 2016	FDA 483	Akorn Operating Company LLC (dba Akorn) - Form 483, 2016-04-04
October, 2009	EIR	Akorn Operating Company LLC (dba Akorn) - EIR, 2009-10-06
May, 2016	FDA 483	Hikma Injectables USA Inc. - Form 483, 2016-05-26
September, 2013	FDA 483	Patheon Biologics (NJ) LLC - Form 483, 2013-09-26
August, 2015	EIR	Alcami Corporation - EIR, 2015-08-26
December, 2010	FDA 483	Sunrise Pharmaceutical Inc - Form 483, 2010-12-20
March, 2023	FDA 483	SPECTRUM LABORATORY PRODUCTS INC. dba SPECTRUM CHEMICAL MFG. CORP. - Form 483, 2023-03-24
May, 2010	FDA 483	Cosette Pharmaceuticals, Inc. - Form 483, 2010-05-17
January, 2012	FDA 483	Actavis Elizabeth LLC - Form 483, 2012-01-13
May, 2015	FDA 483	Liberty Drug & Surgical - Form 483, 2015-05-22
June, 2011	FDA 483	Biochem Laboratory, Inc - Form 483, 2011-06-15
August, 2013	FDA 483	Novel Laboratories, Inc. - Form 483, 2013-09-11
May, 2012	FDA 483	Excelsior Medical LLC - Form 483, 2012-05-14
December, 2013	EIR	CMIC CMO USA CORP - EIR, 2013-12-04
July, 2015	FDA 483	Hikma Injectables USA Inc. - Form 483, 2015-07-13
March, 2011	FDA 483	June Jacobs Labs, LLC - Form 483, 2011-03-21
October, 2016	FDA 483	RARITAN PHARMACEUTICALS INCORPORATED - Form 483, 2016-10-20
January, 2014	FDA 483	Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc. - Form 483, 2014-01-08
December, 2013	FDA 483	CMIC CMO USA CORP - Form 483, 2013-12-04
December, 2012	FDA 483	Cosmax USA, Inc. (Cosmax USA, Corporation) - Form 483, 2012-12-13
September, 2016	FDA 483	Pliva Hrvatska d.o.o. - Form 483, 2016-09-20
March, 2014	FDA 483	Sonar Products, Inc. - Form 483, 2014-03-18
June, 2010	FDA 483	Rutherford Chemicals, LLC - Form 483, 2010-06-04
September, 2010	FDA 483	Kobo Products, Inc - Form 483, 2010-09-30
June, 2010	FDA 483	Packaging Systems, LLC - Form 483, 2010-06-23

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

Total inspections conducted
483 rate
OAI rate
Warning Letter rate
Inspections by Industry, Scope, and Inspection Reason
And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

Pre-Approval Inspection (PAI) trends
The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
Latest 483s: see what the trends are across all FDA Investigators
CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

Full inspection histories for your vendors down to the specific site level
All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more